Also from this source

You just read:

Keryx Biopharmaceuticals Announces that Congress Delays Implementation of Oral-Only ESRD-Related Drugs, Including Phosphate Binders, in the Bundled ESRD Prospective Payment System by Two-Years, until January 2016

News provided by

Keryx Biopharmaceuticals, Inc.

Jan 03, 2013, 08:30 EST